Skip to main content

Overview

The Zeng laboratory is focused on investigating the role of the gut microbiome and diets in maternal-fetal/neonatal immune crosstalk, and the development of neonatal or pediatric inflammatory diseases, such as preterm birth, necrotizing enterocolitis, food allergies, asthma and cancer. Ongoing studies in our laboratory involve in vitro cell biology, microbiology, and immunology assays, disease models in gnotobiotic mice or genetic knockout mice, and examination of clinical samples from newborns, children and pregnant women. Our studies are aimed to identify gut bacteria, bacterial factors or dietary factors that could be potential therapeutic candidates to facilitate appropriate immune responses in the fetus during pregnancy or in the newborn after birth, with the overarching goal of developing preventive approaches to lower the incidence of diseases that may be partly attributed to dysregulated immune cell education in early life.

Zeng Lab Website: www.zeng-lab.org

Highlights

  1. 1
    Science immunology · 2022
    PMID: 35687695PMCID: PMC9375732DOISenior author68 citations
  2. 2
    Gut microbes · 2022
    PMID: 35915556PMCID: PMC9348133DOISenior author53 citations
  3. 3
    Cell · 2025
    JBJulia BrownSYShui YuDSDaniel Sen Hoi WongJGJinghua Gu+9 more →MZMelody Zeng
    PMID: 41412123PMCID: PMC12904261DOISenior author36 citations

Publications

42 publications

Active

9 grants
  • KP
    Age-specific antidepressant-gut microbiome interplay in anti-tumor immunity.
    National Cancer Institute · 2026–2031Career
  • PI
    Regulation of maternal-fetal immune tolerance by gut metabolites
    Bill & Melinda Gates Foundation · 2026–2028
    INV-111343
  • KP
    Wong | American Heart Association Predoctoral Fellowship 2026
    American Heart Association · 2026–2028
    26PRE1562404
  • KP
    Defining the role of premature infant microbial dysbiosis in mediating immune development and response to infection
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024–2027Fellowship
  • KP
    Defining the stress-gut microbiome interplay in anti-tumor B cell response.
    Cancer Research Institute, Inc. · 2024–2027
    CRI5755
  • PI
    Megakaryocyte regulation by the gut microbiome
    National Heart, Lung, and Blood Institute · 2023–2027
  • PI
    Immune regulation by the gut microbiome at the maternal-fetal interface
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2022–2026
  • MPI
    Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis
    National Cancer Institute · 2023–2025
  • PI
    Defining the role of stress-induced changes in the IgG-gut microbiomeneutrophil axis during breast cancer progression and metastasis
    Starr Cancer Consortium · 2023–2025
    SCC I16-0057
Completed grants (3)
  • PI
    Role of gut microbiota-induced IgG in enteric host defense
    National Institute of Diabetes and Digestive and Kidney Diseases · 2019–2023Career· 2 renewals
  • PI
    Interrogating the role of infant gut microbiome in immune responses to RSV infection
    Cornell University · 2022–2022
    CU 222354-01
  • KP
    The role of premature infant dysbiosis in mediating immune development and response to infection
    Biocodex · 2021–2022
    BIO 221663-01

Honors & distinctions

1 honor
  • Hartwell Individual Biomedical Research Award · The Hartwell Foundation · 2021

Clinical research

1 study

Active

1 study
  • PI
    The link between gut dysbiosis and alterations in the metabolome of preterm infants
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)

Available technologies

News mentions

Show 3 more mentions
1 MD student · 4 PhD students · 5 Postdocs

PhD · 4

Postdoc · 5